Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
It has been proposed that diverse anticancer drugs and radiation therapy may induce a mode of cell death with the characteristics of apoptosis. Since apoptosis is under the control of several oncogenes, we analyzed the expression of the protein encoded by the proto-oncogenes bcl-2 and p53. Furthermo...
Auteurs principaux: | Gasparini, G, Bevilacqua, P, Bonoldi, E, Testolin, A, Galassi, A, Verderio, P, Boracchi, P, Guglielmi, R, Pezzella, F |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1995
|
Documents similaires
-
Efficacy and safety of low-dose celecoxib with chemoradiation in locally advanced head-and-neck squamous cell carcinoma
par: Rethinesh Kumar T, et autres
Publié: (2024-07-01) -
Neoadjuvant Concurrent Chemoradiation for Curative Treatment of Penile Squamous Cell Carcinoma
par: Arpit Chhabra, et autres
Publié: (2014-01-01) -
Assessment of Neutrophil-to-Lymphocyte Ratio as A Prognostic Marker in Locally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiation
par: Targain Elisha Servorip, et autres
Publié: (2023-10-01) -
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
par: Thomas F. Cyberski, et autres
Publié: (2024-05-01) -
FRZB: a potential prognostic marker for head and neck squamous cell carcinoma
par: Yunshan Li, et autres
Publié: (2024-05-01)